Literature DB >> 33338479

Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.

Dandan Wu1, Yumin Ke2, Rongrong Xiao3, Jia Liu1, Qingli Li1, Yiwen Wang4.   

Abstract

PURPOSE: Epithelial ovarian cancer (EOC) is a highly fatal gynecological cancer. A long noncoding RNA (lncRNA) gastric cancer-associated lncRNA1 (GClnc1) has been revealed to play critical roles in metastasis. Therefore, the present study aims to explore the correlation between GClnc1 and the metastasis and progression of EOC.
METHODS: First, 57 paired EOC and paracancerous tissues were collected to detect GClnc1 expression by RT-qPCR. Subsequently, OVC1 and SKOV3 cells with GClnc1 silencing/overexpression were developed to detect changes in cell activity, apoptosis, migration and invasion abilities. Then, the subcellular localization of GClnc1 was detected by nuclear/cytoplasmic fractionation, ISH and FISH assays. The binding relationships between GClnc1 and forkhead box protein C2 (FOXC2), and between FOXC2 and NOTCH1 were predicted and verified.
RESULTS: GClnc1 was significantly overexpressed in EOC tissues, and knockdown of GClnc1 inhibited cell viability and promoted apoptosis. Moreover, GClnc1 in the nucleus bound to the transcription factor FOXC2, thereby activating the transcription of NOTCH1. NOTCH1 overexpression enhanced the proliferation and epithelial-mesenchymal transition of SKOV3 and OVC1 cells. Moreover, NOTCH1 activated the NF-κB/Snail signaling. Finally, in vivo experiments demonstrated that GClnc1 knockdown suppressed the growth and metastasis of SKOV3 and OVC1 cells in vivo.
CONCLUSIONS: GClnc1 promoted NOTCH1 transcription by recruiting FOXC2, thereby activating the NF-κB/Snail signaling and promoting EOC cell growth and metastasis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial ovarian cancer; FOXC2; Long noncoding RNA GClnc1; NF-κB/snail signaling; NOTCH1

Year:  2020        PMID: 33338479     DOI: 10.1016/j.yexcr.2020.112422

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.

Authors:  Shuyan Yang; Jing Wang; Rongjie Cheng; Bo Pang; Pengcheng Sun
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-11       Impact factor: 2.629

Review 2.  RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment.

Authors:  Jiangchun Wu; Yong Wu; Qinhao Guo; Simin Wang; Xiaohua Wu
Journal:  J Transl Med       Date:  2022-01-21       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.